Cited by 4,760Diabetes, Cardiovascular Risks, and LipoproteinsCardiovascular Function and Risk FactorsCardiovascular Health and Risk Factors

The DOI matches its Crossref record; 39 of the 39 references it cites were found in a registry or an index.

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Isomaa, Bo, Almgren, Peter, Tuomi, Tiinamaija, Forsén, Björn, Lahti, Kaj, Nissén, Michael, Taskinen, Marja-Riitta, Groop, Leif·2001·Diabetes Care

DOI 10.2337/diacare.24.4.683

Open this paper in CoChat — free account

Abstract

OBJECTIVE—To estimate the prevalence of and the cardiovascular risk associated with the metabolic syndrome using the new definition proposed by the World Health Organization (WHO). RESEARCH DESIGN AND METHODS—A total of 4,483 subjects aged 35–70 years participating in a large family study of type 2 diabetes in Finland and Sweden (the Botnia study) were included in the analysis of cardiovascular risk associated with the metabolic syndrome. In subjects who had type 2 diabetes (n = 1,697), impaired fasting glucose (IFG)/impaired glucose tolerance (IGT) (n = 798), or insulin-resistance with normal glucose tolerance (NGT) (n = 1,988), the metabolic syndrome was defined as presence of at least two of the following risk factors: obesity, hypertension, dyslipidemia, or microalbuminuria. Cardiovascular mortality was assessed in 3,606 subjects with a median follow-up of 6.9 years. RESULTS—In women and men, respectively, the metabolic syndrome was seen in 10 and 15% of subjects with NGT, 42 and 64% of those with IFG/IGT, and 78 and 84% of those with type 2 diabetes. The risk for coronary heart disease and stroke was increased threefold in subjects with the syndrome (P < 0.001). Cardiovascular mortality was markedly increased in subjects with the metabolic syndrome (12.0 vs. 2.2%, P < 0.001). Of the individual components of the metabolic syndrome, microalbuminuria conferred the strongest risk of cardiovascular death (RR 2.80; P = 0.002). CONCLUSIONS—The WHO definition of the metabolic syndrome identifies subjects with increased cardiovascular morbidity and mortality and offers a tool for comparison of results from different studies.

Integrity signals

Registry

Crossref · 10.2337/diacare.24.4.683

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus
Randle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093
Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease
DeFronzo, R. A., & Ferrannini, E. (1991) · Diabetes Care · doi:10.2337/diacare.14.3.173 · Cited by 4,555
Cardiovascular Survey Methods.
Rose, G., & Blackburn, H. (1968) · Annals of Internal Medicine · doi:10.7326/0003-4819-69-6-1335_2 · Cited by 3,090
Myocardial infarction and coronary deaths in the World Health Organization MONICA Project. Registration procedures, event rates, and case-fatality rates in 38 populations from 21 countries in four continents.
Tunstall-Pedoe, H., Kuulasmaa, K., Amouyel, P., Arveiler, D., Rajakangas, A.-M., & Pająk, A. (1994) · Circulation · doi:10.1161/01.cir.90.1.583 · Cited by 2,260
Comment on the provisional report from the WHO consultation
(1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00059.x · Cited by 1,820
Role of Fatty Acids in the Pathogenesis of Insulin Resistance and NIDDM
Boden, G. (1997) · Diabetes · doi:10.2337/diab.46.1.3 · Cited by 1,728
The Deadly Quartet
Kaplan, N. M. (1989) · Archives of Internal Medicine · doi:10.1001/archinte.149.7.1514 · Cited by 1,672
Hyperinsulinemia. A link between hypertension obesity and glucose intolerance.
Modan, M., Halkin, H., Almog, S., Lusky, A., Eshkol, A., Shefi, M., Shitrit, A., & Fuchs, Z. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111776 · Cited by 1,465

Show all 36 references

Research works printed but not linked: 2

Descovich GC, Benassi B, Cancelli V, D’Addato S, De Simone, Dormi A: An epidemic view of the plurimetabolic syndrome. In Diabetes, Obesity and Hyperlipidemias. V. The Plurimetabolic Syndrome Crepaleli G, Tiengo A, Manzato E, Eds. Amsterdam, Netherlands, Elsevier Science, 1993, p. 31–39
Bouchard C, Perusse L: Genetics of causes and manifestations of the metabolic syndrome. In Diabetes, obesity and hyperlipidemia: V. The plurimetabolic syndrome Crepaldi G, Tiengo A, Manzato E, Eds., Amsterdam, Elsevier Science, 1993, p. 67–74

Sorted by citations

Items 801–900 of 1,022

GUIDELINES ON DIABETES, PRE-DIABETES, AND CARDIOVASCULAR DISEASES
Rydén, L., Standl, E., Bartnik, M., den Berghe, G. V., Betteridge, J. D., de Boer, M. J., Cosentino, F., Jönsson, B., Laakso, M., Malmberg, K., et al. (2007) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2007-3-4-71-99 · Cited by 81
Abdominal obesity is essential for the risk of venous thromboembolism in the metabolic syndrome: the Tromsø study
Borch, K. H., Brækkan, S. K., Mathiesen, E. B., Njølstad, I., Wilsgaard, T., Störmer, J., & HANSEN, J. ‐. (2008) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2008.03234.x · Cited by 82
The effect of Cissus quadrangularis (CQR-300) and a Cissus formulation (CORE) on obesity and obesity-induced oxidative stress.
Oben, J. E., Mandob, D. E., Fomekong, G. I. D., Soukontoua, Y. B., & Agbor, G. A. (2007) · Lipids in Health and Disease · doi:10.1186/1476-511x-6-4 · Cited by 82
Uncoupling protein 2 and metabolic diseases
Sreedhar, A., & Zhao, Y. (2017) · Mitochondrion · doi:10.1016/j.mito.2017.03.005 · Cited by 83
American Association of Clinical Endocrinologists (AACE) Consensus Conference on the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2003) · Diabetes Care · doi:10.2337/diacare.26.4.1297 · Cited by 81
Prevalence of atherosclerotic vascular disease among subjects with the metabolic syndrome with or without diabetes mellitus: the METS-GREECE Multicentre Study
Athyros, V. G., Mikhailidis, D. P., Papageorgiou, A. A., Didangelos, T., Ganotakis, E. S., Symeonidis, A. N., Daskalopoulou, S. S., Kakafika, A. I., & Elisaf, M. (2004) · Current Medical Research and Opinion · doi:10.1185/030079904x5599 · Cited by 81
Journal of Experimental and Clinical Medicine
(2021) · Journal of Experimental and Clinical Medicine · doi:10.5835/jecm · Cited by 80
A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation
Mehdi, S., Wani, S. U. D., Krishna, K. L., Kinattingal, N., & Roohi, T. F. (2023) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2023.101571 · Cited by 87
Metabolic and vascular insulin resistance: partners in the pathogenesis of cardiovascular disease in diabetes
Horton, W. B., Love, K. M., Gregory, J. M., Liu, Z., & Barrett, E. J. (2025) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00826.2024 · Cited by 95
Prevalence of Metabolic Syndrome in Obese Children and Adolescents using Three Different Criteria and Evaluation of Risk Factors - Original Article
Sangün, Ö., Dündar, B. N., Köşker, M., Köşker, M., Pirgon, Ö., & Dündar, N. O. (2011) · Journal of Clinical Research in Pediatric Endocrinology · doi:10.4274/jcrpe.v3i2.15 · Cited by 81
Comparison of rosuvastatin with atorvastatin, simvastatin and pravastatin in achieving cholesterol goals and improving plasma lipids in hypercholesterolaemic patients with or without the metabolic syndrome in the MERCURY I trial
Stender, S., Schuster, H., Barter, P. J., Watkins, C. J., Kallend, D. G., & on behalf of the MERCURY I Study Group (2004) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2004.00450.x · Cited by 81
Diet‐induced central obesity and insulin resistance in rabbits
Zhao, S., Chu, Y., Zhang, C., Lin, Y., Xu, K., Yang, P., Fan, J., & Liu, E. (2007) · Journal of Animal Physiology and Animal Nutrition · doi:10.1111/j.1439-0396.2007.00723.x · Cited by 81
Cataract subtype risk factors identified from the Korea National Health and Nutrition Examination survey 2008–2010
Rim, T. H., Kim, M. H., Kim, W. C., Kim, T., & Kim, E. K. (2014) · BMC Ophthalmology · doi:10.1186/1471-2415-14-4 · Cited by 81
Association between serum uric acid and the metabolic syndrome among a middle- and old-age Chinese population
Dai, X., Yuan, J., Yao, P., Yang, B., Gui, L., Zhang, X., Guo, H., Wang, Y., Chen, W., Wei, S., et al. (2013) · European Journal of Epidemiology · doi:10.1007/s10654-013-9829-4 · Cited by 81
Metabolic Syndrome and Lumbar Spine Fusion Surgery
Memtsoudis, S. G., Kirksey, M., Ma, Y., Chiu, Y. L., Mazumdar, M., Pumberger, M., & Girardi, F. P. (2011) · Spine · doi:10.1097/brs.0b013e31823a3a13 · Cited by 81
Microcirculation and the Metabolic Syndrome
Wiernsperger, N. F., Nivoit, P., Kraemer‐Aguiar, L. G., & Bouskela, E. (2007) · Microcirculation · doi:10.1080/10739680701285617 · Cited by 81
The Cardiometabolic Syndrome as a Cardiovascular Risk Factor
Govindarajan, G., Whaley‐Connell, A. T., Mugo, M. N., Stump, C. S., & Sowers, J. R. (2005) · The American Journal of the Medical Sciences · doi:10.1097/00000441-200512000-00009 · Cited by 81
Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets
Plutzky, J., Viberti, G. C., & Haffner, S. M. (2002) · Journal of Diabetes and its Complications · doi:10.1016/s1056-8727(02)00202-7 · Cited by 81
Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes
Trost, S. U., Pratley, R. E., & Sobel, B. E. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0052-5 · Cited by 81
Can Adoption of Regular Exercise Later in Life Prevent Metabolic Risk for Cardiovascular Disease?
Petrella, R. J., Lattanzio, C. N., Demeray, A., Varallo, V., & Blore, R. (2005) · Diabetes Care · doi:10.2337/diacare.28.3.694 · Cited by 80
Prevalence of the metabolic syndrome in unipolar major depression
Kahl, K. G., Greggersen, W., Schweiger, U., Cordes, J., Balijepalli, C., Lösch, C., & Moebus, S. (2012) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-011-0277-4 · Cited by 79
Relationship between metabolic syndrome definitions for children and adolescents and intima-media thickness
Reinehr, T., Wunsch, R., de Sousa, G., & Toschke, A. M. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2007.09.041 · Cited by 80
Periodontal Status and Metabolic Syndrome in Middle‐Aged Japanese
Fukui, N., Shimazaki, Y., Shinagawa, T., & Yamashita, Y. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.110605 · Cited by 81
Metabolic Consequences of Obstructive Sleep Apnea in Adolescents with Obesity: A Systematic Literature Review and Meta-Analysis
Patinkin, Z. W., Feinn, R., & Santos, M. (2016) · Childhood Obesity · doi:10.1089/chi.2016.0248 · Cited by 83
Obesity, Metabolic Syndrome and Risk of Atrial Fibrillation: A Swedish, Prospective Cohort Study
Nyström, P., Carlsson, A. C., Leander, K., Fairé, U. D., Hellénius, M.-L., & Gigante, B. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127111 · Cited by 80
Prevalence of the metabolic syndrome in Peruvian Andean hispanics: The PREVENCION study
Medina‐Lezama, J., Zea-Díaz, H., Morey‐Vargas, O. L., Bolaños-Salazar, J. F., Muñoz-Atahualpa, E., Dowall, M. P. M., Corrales‐Medina, F. F., Valdivia-Ascuña, Z., Cuba-Bustinza, C., Diaz, S. P., et al. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.04.004 · Cited by 76
Prevalence of the metabolic syndrome in Zhejiang Chinese obese children and adolescents and the effect of metformin combined with lifestyle intervention
Fu, J.-F., Liang, L., Zou, C.-C., Hong, F., Wang, C.-L., Wang, X.-M., & Zhao, Z.-Y. (2006) · International Journal of Obesity · doi:10.1038/sj.ijo.0803453 · Cited by 80
Organogelators as a Saturated Fat Replacer for Structuring Edible Oils
Siraj, N., Shabbir, M. A., Ahmad, T. A. M. M., Sajjad, A., Khan, M. R., Khan, M. I., & Butt, M. S. (2015) · International Journal of Food Properties · doi:10.1080/10942912.2014.951891 · Cited by 80
Lifestyle Variables, Non‐traditional Cardiovascular Risk Factors, and the Metabolic Syndrome in an Aboriginal Canadian Population
Liu, J., Young, T. K., Zinman, B., Harris, S. B., Connelly, P. W., & Hanley, A. J. (2006) · Obesity · doi:10.1038/oby.2006.65 · Cited by 80
Differences in the prevalence of metabolic syndrome in urban and rural India: a problem of urbanization
Prabhakaran, D., Chaturvedi, V., Shah, P., Manhapra, A., Jeemon, P., Shah, B., & Reddy, K. S. (2007) · Chronic Illness · doi:10.1177/1742395307079197 · Cited by 80
Cardiovascular disease, metabolic syndrome and erectile dysfunction
Müller, A., & Mulhall, J. P. (2006) · Current Opinion in Urology · doi:10.1097/01.mou.0000250284.83108.a6 · Cited by 78
Prevalence of the Metabolic Syndrome in German Women with Polycystic Ovary Syndrome
Hahn, S., Tan, S., Sack, S., Kimmig, R., Quadbeck, B., Mann, K., & Janssen, O. E. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-967093 · Cited by 80
Hopes, disillusions and more hopes from vitamin C
Tullio, M. C. D., & Arrigoni, O. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3203-8 · Cited by 80
Burden of metabolic syndrome among HIV-infected patients in Southern Ethiopia
Tesfaye, D. Y., Kinde, S., Medhin, G., Megerssa, Y. C., Hirigo, A. T., Tadesse, E., & Shimelis, T. (2014) · Diabetes & Metabolic Syndrome Clinical Research & Reviews · doi:10.1016/j.dsx.2014.04.008 · Cited by 80
Effects of lifestyle intervention on health care costs: improving control with activity and nutrition (ICAN)
Wolf, A. M., Siadaty, M., Yaeger, B., Conaway, M. R., Crowther, J. Q., Nadler, J. L., & Bovbjerg, V. E. (2007) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2007.05.015 · Cited by 79
Impact of the individual components of the metabolic syndrome and their different combinations on the prevalence of atherosclerotic vascular disease in type 2 diabetes: the Diabetes in Germany (DIG) study
Markolf Hanefeld, E., Koehler, C., Gallo, S., Benke, I., & Ott, P. (2007) · Cardiovascular Diabetology · doi:10.1186/1475-2840-6-13 · Cited by 79
p38 Mitogen-Activated Protein Kinase: A Critical Node Linking Insulin Resistance and Cardiovascular Diseases in Type 2 Diabetes Mellitus
Liu, Z., & Cao, W. (2009) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153009787582397 · Cited by 80
Association between serum uric acid levels and cardiovascular disease in middle-aged and elderly Chinese individuals
Qin, L., Yang, Z. H., Gu, H., Lu, S., Shi, Q., Xing, Y., Li, X., Li, R., Ning, G., & Su, Q. (2014) · BMC Cardiovascular Disorders · doi:10.1186/1471-2261-14-26 · Cited by 79
Serum levels of fibroblast growth factor‐21 are increased in chronic and acute renal dysfunction
Hindricks, J., Ebert, T., Bachmann, A., Kralisch, S., Lössner, U., Kratzsch, J., Stolzenburg, J., Dietel, A., Beige, J., Anders, M. S., et al. (2013) · Clinical Endocrinology · doi:10.1111/cen.12380 · Cited by 80
Small, Dense Lipoprotein Particles and Reduced Paraoxonase-1 in Patients with the Metabolic Syndrome
Blatter, M.-C., Kalix, B., Morabia, A., & James, R. W. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1295 · Cited by 79
Predicting Metabolic Syndrome by Visceral Adiposity Index, Body Roundness Index and a Body Shape Index in Adults: A Cross-Sectional Study from the Iranian RaNCD Cohort Data
Baveicy, K., Mostafaei, S., Darbandi, M., Hamzeh, B., Najafi, F., & Pasdar, Y. (2020) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s238153 · Cited by 76
Effects of eight weeks of aerobic interval training and of isoinertial resistance training on risk factors of cardiometabolic diseases and exercise capacity in healthy elderly subjects
Bruseghini, P., Calabria, E., Tam, E., Milanese, C., Oliboni, E. S., Pezzato, A., Pogliaghi, S., Salvagno, G. L., Schena, F. F., Mucelli, R. P., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4031 · Cited by 83
Discovery and Metabolic Stabilization of Potent and Selective 2-Amino-N-(adamant-2-yl) Acetamide 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibitors
Rohde, J. J., Pliushchev, M. A., Sorensen, B. K., Wódka, D., Shuai, Q., Wang, J., Fung, S., Monzon, K., Chiou, W. J. H., Pan, L., et al. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm0609364 · Cited by 78
The association between metabolic syndrome, microalbuminuria and impaired renal function in the general population: impact on cardiovascular disease and mortality
Klausen, K. P., Parving, H. ‐., Scharling, H., & Jensen, J. S. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01839.x · Cited by 78
Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population
Choi, K. M., Kim, S. M., Kim, Y.-E., Choi, D. S., Baik, S. H., & Lee, J. (2007) · Metabolism · doi:10.1016/j.metabol.2006.12.003 · Cited by 78
Cardiovascular risk factor investigation: a pediatric issue
Rodrigues, A., Abreu, G. R., Resende, R. S., Gonçalves, W. L. S., & Gouvêa (2013) · International Journal of General Medicine · doi:10.2147/ijgm.s41480 · Cited by 78
Prevalence and trends of metabolic syndrome in Korea: Korean National Health and Nutrition Survey 1998–2001
Park, H., Kim, S. M., Lee, J. S., Lee, J., Han, J. H., Yoon, D. K., Baik, S. H., Choi, D. S., & Choi, K. M. (2006) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2005.00569.x · Cited by 78
Early marginal ulcer following Roux-en-Y gastric bypass under proton pump inhibitor treatment: prospective multicentric study
Junior, A. B. G., Rossi, M., de Lima, S. E., Brenner, A. S., & Gomes, C. A. R. (2010) · Arquivos de Gastroenterologia · doi:10.1590/s0004-28032010000200003 · Cited by 77
A new dietary strategy for long-term treatment of the metabolic syndrome is compared with the American Heart Association (AHA) guidelines: the MEtabolic Syndrome REduction in NAvarra (RESMENA) project
de la Iglesia, R., Lopez‐Legarrea, P., Abete, I., Bondia‐Pons, I., Navas‐Carretero, S., Forga, L., Martínez, J. A., & Zulet, M. Á. (2013) · British Journal Of Nutrition · doi:10.1017/s0007114513002778 · Cited by 78
Dietary Regulation of Histone Acetylases and Deacetylases for the Prevention of Metabolic Diseases
Pham, T. X., & Lee, J. (2012) · Nutrients · doi:10.3390/nu4121868 · Cited by 78
Psyllium Arabinoxylan: A Versatile Biomaterial for Potential Medicinal and Pharmaceutical Applications
Hussain, M. A., Muhammad, G., Jantan, I., & Bukhari, S. N. A. (2015) · Journal of macromolecular science. Part C, Reviews in macromolecular chemistry and physics/Journal of macromolecular science. Reviews in macromolecular chemistry and physics · doi:10.1080/15583724.2015.1078351 · Cited by 79
Prevalence of Metabolic Syndrome and Individual Criteria in College Students
Fernandes, J., & Lofgren, I. E. (2011) · Journal of American College Health · doi:10.1080/07448481.2010.508084 · Cited by 78
New Treatment Strategies for Patients with Hypertension and Insulin Resistance
Kurtz, T. W. (2006) · The American Journal of Medicine · doi:10.1016/j.amjmed.2006.01.011 · Cited by 78
Low HDL-C: A secondary target of dyslipidemia therapy
Rosenson, R. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.021 · Cited by 81
Definitions of the Insulin Resistance Syndrome
Bloomgarden, Z. T. (2004) · Diabetes Care · doi:10.2337/diacare.27.3.824 · Cited by 78
Association of the metabolic syndrome with mortality and major adverse cardiac events: A large chronic kidney disease cohort
Pammer, L. M., Lamina, C., Schultheiß, U. T., Kotsis, F., Kollerits, B., Stockmann, H., Lipovsek, J., Meiselbach, H., Busch, M., Eckardt, K., et al. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13355 · Cited by 76
A Complex Web of Risks for Metabolic Syndrome
Salsberry, P. J., Corwin, E. J., & Reagan, P. B. (2007) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2007.03.017 · Cited by 78
Prevalence of the Metabolic Syndrome in Middle-Aged Men and Women
Villegas, R., Perry, I. J., Creagh, D., Hinchion, R., & O’Halloran, D. (2003) · Diabetes Care · doi:10.2337/diacare.26.11.3198-a · Cited by 77
Association between television viewing and the risk of metabolic syndrome in a community-based population
Chang, P.-C., Li, T., Wu, M., Liu, C.-S., Li, C., Chen, C., Lin, W., Yang, S.-Y., & Lin, C. (2008) · BMC Public Health · doi:10.1186/1471-2458-8-193 · Cited by 77
Non-alcoholic fatty liver disease (NAFLD) and cardiovascular disease: An open question
Loria, P., Lonardo, A., Bellentani, S., Day, C., Marchesini, G., & Carulli, N. (2007) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2007.01.007 · Cited by 77
Associations of Visceral and Subcutaneous Fat Areas With the Prevalence of Metabolic Risk Factor Clustering in 6,292 Japanese Individuals
Matsushita, Y., Nakagawa, T., Yamamoto, S., Takahashi, Y., Yokoyama, T., Noda, M., & Mizoue, T. (2010) · Diabetes Care · doi:10.2337/dc10-0120 · Cited by 77
Urinary Smad1 Is a Novel Marker to Predict Later Onset of Mesangial Matrix Expansion in Diabetic Nephropathy
Mima, A., Arai, H., Matsubara, T., Abe, H., Nagai, K., Tamura, Y., Torikoshi, K., Araki, M., Kanamori, H., Takahashi, T., et al. (2008) · Diabetes · doi:10.2337/db07-1726 · Cited by 77
The Metabolic Ghetto
Wells, J. C. K. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9780511972959 · Cited by 83
The metabolic syndrome: targeting dyslipidaemia to reduce coronary risk.
Ginsberg, H. N., & Stalenhoef, A. F. H. (2003) · PubMed · doi:10.1097/01.hjr.0000060840.46106.ea · Cited by 77
Age-Associated Increase in Abdominal Obesity and Insulin Resistance, and Usefulness of AHA/NHLBI Definition of Metabolic Syndrome for Predicting Cardiovascular Disease in Japanese Elderly with Type 2 Diabetes Mellitus
Sakurai, T., Iimuro, S., Araki, A., Umegaki, H., Ohashi, Y., Yokono, K., & Ito, H. (2009) · Gerontology · doi:10.1159/000246970 · Cited by 81
Beneficial Effects of Korean Traditional Diets in Hypertensive and Type 2 Diabetic Patients
Jung, S., Park, S., Choi, E.-K., Cha, Y., Cho, B.-H., Kim, Y.-G., Kim, M., Song, W. O., Park, T.-S., Ko, J., et al. (2014) · Journal of Medicinal Food · doi:10.1089/jmf.2013.3042 · Cited by 76
The metabolic syndrome and high C-reactive protein: prevalence and differences by sex in a southern-European population-based cohort
Bo, S., Gentile, L., Ciccone, G., Baldi, C., Benini, L., Dusio, F., de Lucia, C., Forastiere, G., Nuti, C., Cassader, M., et al. (2005) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.561 · Cited by 76
The Metabolic Syndrome and Mind-Body Therapies: A Systematic Review
Anderson, J. G., & Taylor, A. G. (2011) · Journal of Nutrition and Metabolism · doi:10.1155/2011/276419 · Cited by 76
Selected Dietary Nutrients and the Prevalence of Metabolic Syndrome in Adult Males and Females in Saudi Arabia: A Pilot Study
Al‐Daghri, N. M., Khan, N., Alkharfy, K. M., Al-Attas, O. S., Alokail, M. S., Alfawaz, H., Al-Othman, A. M., & Vanhoutte, P. M. (2013) · Nutrients · doi:10.3390/nu5114587 · Cited by 76
Metabolic Syndrome Amplifies the LDL-Cholesterol Associated Increases in Carotid Atherosclerosis
Kawamoto, R., Tomita, H., Oka, Y., Kodama, A., & Kamitani, A. (2005) · Internal Medicine · doi:10.2169/internalmedicine.44.1232 · Cited by 76
The metabolic syndrome: an emerging health epidemic in women
Steinbaum, S. (2004) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2003.08.005 · Cited by 75
Correlation between metabolic syndrome and knee osteoarthritis: data from the Korean National Health and Nutrition Examination Survey (KNHANES)
Han, C. D., Yang, I. H., Lee, W.-S., Park, Y. J., & Park, K. K. (2013) · BMC Public Health · doi:10.1186/1471-2458-13-603 · Cited by 76
Small for gestational age status is associated with metabolic syndrome in overweight children
Reinehr, T., Kleber, M., & Toschke, A. M. (2009) · European Journal of Endocrinology · doi:10.1530/eje-08-0914 · Cited by 77
Factors accounting for the rise in health-care spending in the United States: The role of rising disease prevalence and treatment intensity
Thorpe, K. E. (2006) · Public Health · doi:10.1016/j.puhe.2006.09.001 · Cited by 76
The framingham risk score, diet, and inflammatory markers in Korean men with metabolic syndrome
Sohn, C., Kim, J., & Bae, W.-K. (2012) · Nutrition Research and Practice · doi:10.4162/nrp.2012.6.3.246 · Cited by 79
The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011–2016
Zhu, L., Spence, C., Yang, W. J., & Grace, X. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9123871 · Cited by 82
Hypertension and Diabetes
Grossman, E., & Messerli, F. H. (2008) · KARGER eBooks · doi:10.1159/000115189 · Cited by 76
Should Central Obesity Be an Optional or Essential Component of the Metabolic Syndrome?
Lee, J., Ma, S., Heng, D., Tan, C.-E., Chew, S., Hughes, K., & Tai, E. S. (2007) · Diabetes Care · doi:10.2337/dc06-1866 · Cited by 75
Oxidative stress and antioxidant status in elderly diabetes mellitus and glucose intolerance patients
Atlı, T., Keven, K., Avcı, A., Kutlay, S., Türkçapar, N., Varlı, M., Aras, S., Ertuğ, E., & Canbolat, O. (2004) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2004.04.065 · Cited by 73
Metabolic Syndrome in Children and Adolescents: a Critical Approach Considering the Interaction between Pubertal Stage and Insulin Resistance
Reinehr, T. (2016) · Current Diabetes Reports · doi:10.1007/s11892-015-0695-1 · Cited by 82
The insulin resistance syndrome: implications for thrombosis and cardiovascular disease
Juhan-Vague, I., Morange, P., & Alessi, M. (2002) · Pathophysiology of Haemostasis and Thrombosis · doi:10.1159/000073579 · Cited by 75
Dysfunction of the Blood-Brain Barrier—A Key Step in Neurodegeneration and Dementia
Noe, C. R., Noe-Letschnig, M., Handschuh, P. A., Noe, C. A., & Lanzenberger, R. R. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.00185 · Cited by 76
The Metabolic Syndrome: Are Rural Residents at Increased Risk?
Trivedi, T., Liu, J., Probst, J. C., & Martin, A. B. (2012) · The Journal of Rural Health · doi:10.1111/j.1748-0361.2012.00422.x · Cited by 75
Visit-to-Visit Blood Pressure Variability Is a Novel Risk Factor for the Development and Progression of Diabetic Nephropathy in Patients With Type 2 Diabetes
Okada, H., Fukui, M., Tanaka, M., Matsumoto, S., Mineoka, Y., Nakanishi, N., Asano, M., Yamazaki, M., Hasegawa, G., & Nakamura, N. (2013) · Diabetes Care · doi:10.2337/dc12-2087 · Cited by 74
Characteristics and prevalence of the metabolic syndrome among three ethnic groups in Canada
Liu, J., Hanley, A. J., Young, T. K., Harris, S. B., & Zinman, B. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803179 · Cited by 79
Household Wealth and the Metabolic Syndrome in the Whitehall II Study
Perel, P., Langenberg, C., Ferrie, J. E., Moser, K. A., Brunner, E. J., & Marmot, M. G. (2006) · Diabetes Care · doi:10.2337/dc06-0022 · Cited by 74
Therapeutic potential of melanin-concentrating hormone-1 receptor antagonists for the treatment of obesity
Kowalski, T. J., & McBriar, M. D. (2004) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.13.9.1113 · Cited by 74
Effect of vildagliptin and pravastatin combination on cholesterol efflux in adipocytes
Mostafa, A. M., Hamdy, N. Μ., Abdel‐Rahman, S. Z., & EL-Mesallamy, H. O. (2016) · IUBMB Life · doi:10.1002/iub.1510 · Cited by 73
PCOS-GWAS Susceptibility Variants in THADA, INSR, TOX3, and DENND1A Are Associated With Metabolic Syndrome or Insulin Resistance in Women With PCOS
Tian, Y., Li, J., Su, S., Cao, Y., Wang, Z., Zhao, S., & Zhao, H. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00274 · Cited by 77
[767] METABOLIC SYNDROME IS ASSOCIATED WITH SEVERE FIBROSIS IN CHRONIC VIRAL HEPATITIS AND NON-ALCOHOLIC STEATOHEPATITIS
Tsochatzis, E. A., Papatheodoridis, G., Manesis, E. K., Kafiri, G., & Archimandritis, A. J. (2007) · Journal of Hepatology · doi:10.1016/s0168-8278(07)62365-4 · Cited by 73
The Prevalence of the Metabolic Syndrome among the Multiethnic Population of the United Arab Emirates: A Report of a National Survey
Malik, M., & Abdel‐Razig, S. (2008) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2008.0006 · Cited by 73
An urban–rural comparison of the prevalence of the metabolic syndrome in Eastern China
Weng, X., Liu, Y., Ma, J., Wang, W., Yang, G., & Caballero, B. H. (2007) · Public Health Nutrition · doi:10.1017/s1368980007226023 · Cited by 73
Parity and the metabolic syndrome in older Chinese women: the Guangzhou Biobank Cohort Study
Lao, X. Q., Thomas, G. N., Jiang, C. Q., Zhang, W. S., Yin, P., Schooling, C. M., Heys, M., Leung, G. M., Adab, P., Cheng, K. K., et al. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02615.x · Cited by 73
Metabolic syndrome and obsessive–compulsive disorder: a naturalistic Italian study
Albert, U., Aguglia, A., Chiarle, A., Bogetto, F., & Maina, G. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.10.004 · Cited by 73
Educational disparities in the metabolic syndrome in a rapidly changing society—the case of South Korea
Kim, M., Kim, M.-K., Choi, B. Y., & Shin, Y.-J. (2005) · International Journal of Epidemiology · doi:10.1093/ije/dyi175 · Cited by 73
Risk and Protective Factors for Cause-Specific Mortality After Spinal Cord Injury
Krause, J. S., Cao, Y., DeVivo, M. J., & DiPiro, N. D. (2016) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/j.apmr.2016.07.001 · Cited by 80
Uric acid concentration in subjects at risk of type 2 diabetes mellitus: Relationship to components of the metabolic syndrome
da Costa, A. M., Igualaacute, I., Bedini, J. L., Quintoacute, L., & Conget, I. (2002) · Metabolism · doi:10.1053/meta.2002.30523 · Cited by 72
Relationship between Metabolic Syndrome and Cigarette Smoking in the Japanese Population
Miyatake, N., Wada, J., Kawasaki, Y., Nishii, K., Makino, H., & Numata, T. (2006) · Internal Medicine · doi:10.2169/internalmedicine.45.1850 · Cited by 72
Psoriasis and the metabolic syndrome
Alsufyani, M. A., Golant, A., & Lebwohl, M. (2010) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2010.01307.x · Cited by 71
The Impact of the Components of Metabolic Syndrome on Heart Rate Variability: Using the NCEP‐ATP III and IDF Definitions
Min, K., Min, J., Paek, D., & Cho, S. (2008) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2008.01045.x · Cited by 72

Authors: Isomaa, B., Almgren, P., Tuomi, T., Forsén, B., Lahti, K., Nissén, M., Taskinen, M.-R., & Groop, L.
Affiliations: Department of Internal Medicine, Jakobstad Hospital, Jakobstad, Finland
Lund University (SE)
Helsinki University Hospital (FI)
Närpes Health Center, Närpes
Vasa Health Center
Vaasa Central Hospital (FI)
ORCID: Almgren, Peter
Taskinen, Marja-Riitta
Groop, Leif
Venue: Diabetes Care
Publisher: American Diabetes Association
Published: 2001-04-01
Volume: 24
Issue: 4
Pages: 683-689
ISSN: 0149-5992 (ISSN-L)
1935-5548
DOI: 10.2337/diacare.24.4.683
OpenAlex: W1986349550
Cited by: 4,760
References: 36
Citations by year: 2026: 27 · 2025: 70 · 2024: 93 · 2023: 88 · 2022: 123 · 2021: 132 · 2020: 128 · 2019: 137 · 2018: 139 · 2017: 153 · 2016: 185 · 2015: 198 · 2014: 218 · 2013: 211 · 2012: 222
FWCI: 100.87
Type: journal article
Language: en
Open access: closed
Locations: Diabetes Care (publishedVersion)
PubMed (publishedVersion)
Lund University Publications (Lund University) (submittedVersion)
Funders: Svenska Läkaresällskapet
Topics: Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Function and Risk Factors
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Health and Risk Factors
Keywords: metabolic syndrome, cardiovascular mortality, cardiovascular morbidity, type 2 diabetes, impaired fasting glucose, impaired glucose tolerance, insulin resistance, microalbuminuria, coronary artery disease, stroke, obesity, hypertension, dyslipidemia, WHO definition
MeSH terms: Adult, Age Factors, Aged, Albuminuria, Blood Glucose, Cardiovascular Diseases, Cholesterol, Diabetes Mellitus, Type 2, Family, Female, Finland, Glycated Hemoglobin, Humans, Hyperlipidemias, Hypertension, Insulin Resistance, Cholesterol, HDL, Male, Middle Aged, Morbidity, Obesity, Risk Factors, Sex Factors, Sweden, Triglycerides, Prevalence, Glucose Intolerance

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Cardiovascular Morbidity and Mortality Associated With the Metabolic Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks